M. K. Kathiravan, Senthil M Palaniappan, Narayanan Jayasankar
{"title":"水生生态系统中作为污染物的药物——心血管、抗糖尿病、类固醇及相关药物","authors":"M. K. Kathiravan, Senthil M Palaniappan, Narayanan Jayasankar","doi":"10.9734/bpi/mono/978-93-91882-00-6/ch5","DOIUrl":null,"url":null,"abstract":"Drugs like \\(\\beta\\)-blockers (atenolol, propranolol, metoprolol), ACE inhibitors (captopril, enalapril, lisinopril, ramipril, fosinopril, quinapril), angiotensin (AT1) receptor blockers (losartan, candesartan, valsartan, telmisartan), \\(\\alpha\\)-blockers (prazosin, terazosin, doxazosin, phentolamine, phenoxybenzamine), central sympatholytics (clonidine, methyldopa), cardiac glycosides (digoxin, digitoxin), sympathetic drugs (adrenaline, dopamine, isoprenaline), anticholinergic drugs (atropine, scopolamine), xanthines (theophylline, theobromine), nitrates (glyceryl trinitrate, isosorbide dinitrate), calcium antagonists (verapamil, diltiazem) and K-channel openers (nicorandil) are used for the treatment of the cardiovascular disorder [1]. Recently a study was conducted on the occurrence of cardiovascular drugs in surface waters at a global scale. The study had 82 cardiovascular drugs out of which 58 (~71%) were detected at least once in the water bodies. The study also revealed that only 10% of the aquatic pollution was caused by the commonly prescribed antihypertensives (6% by angiotensin receptor-II antagonist and 4% by ACE inhibitors). The maximum contribution as a source of pollutants were from \\(\\beta\\)-blockers (atenolol, metoprolol, and propranolol) at 38% and 36% to lipid regulating agents (gemfibrozil, bezafibrate and clofibric acid). The ecotoxicity caused by these cardiovascular drugs was further limited to about 24%. The drugs that are a major risk to the aquatic organisms include propranolol, metoprolol, lipid regulating agents, bezafibrate, and atorvastatin. The partition coefficient (Log P) value of cardiovascular drugs ranges from 0.6 for atenolol to 7.7 for telmisartan that results in bioaccumulation in the environmental matrices. Based on the presence of cardiovascular drugs in the aquatic ecosystem, the water pollutants are divided into three major contaminants, municipal water, surface water, and drinking water.","PeriodicalId":19835,"journal":{"name":"Pharmaceuticals in Water","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Pharmaceuticals as Pollutants in the Aquatic Ecosystem – Cardiovascular, Anti-diabetic, Steroids and Related Drugs\",\"authors\":\"M. K. Kathiravan, Senthil M Palaniappan, Narayanan Jayasankar\",\"doi\":\"10.9734/bpi/mono/978-93-91882-00-6/ch5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drugs like \\\\(\\\\beta\\\\)-blockers (atenolol, propranolol, metoprolol), ACE inhibitors (captopril, enalapril, lisinopril, ramipril, fosinopril, quinapril), angiotensin (AT1) receptor blockers (losartan, candesartan, valsartan, telmisartan), \\\\(\\\\alpha\\\\)-blockers (prazosin, terazosin, doxazosin, phentolamine, phenoxybenzamine), central sympatholytics (clonidine, methyldopa), cardiac glycosides (digoxin, digitoxin), sympathetic drugs (adrenaline, dopamine, isoprenaline), anticholinergic drugs (atropine, scopolamine), xanthines (theophylline, theobromine), nitrates (glyceryl trinitrate, isosorbide dinitrate), calcium antagonists (verapamil, diltiazem) and K-channel openers (nicorandil) are used for the treatment of the cardiovascular disorder [1]. Recently a study was conducted on the occurrence of cardiovascular drugs in surface waters at a global scale. The study had 82 cardiovascular drugs out of which 58 (~71%) were detected at least once in the water bodies. The study also revealed that only 10% of the aquatic pollution was caused by the commonly prescribed antihypertensives (6% by angiotensin receptor-II antagonist and 4% by ACE inhibitors). The maximum contribution as a source of pollutants were from \\\\(\\\\beta\\\\)-blockers (atenolol, metoprolol, and propranolol) at 38% and 36% to lipid regulating agents (gemfibrozil, bezafibrate and clofibric acid). The ecotoxicity caused by these cardiovascular drugs was further limited to about 24%. The drugs that are a major risk to the aquatic organisms include propranolol, metoprolol, lipid regulating agents, bezafibrate, and atorvastatin. The partition coefficient (Log P) value of cardiovascular drugs ranges from 0.6 for atenolol to 7.7 for telmisartan that results in bioaccumulation in the environmental matrices. Based on the presence of cardiovascular drugs in the aquatic ecosystem, the water pollutants are divided into three major contaminants, municipal water, surface water, and drinking water.\",\"PeriodicalId\":19835,\"journal\":{\"name\":\"Pharmaceuticals in Water\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceuticals in Water\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/bpi/mono/978-93-91882-00-6/ch5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceuticals in Water","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/mono/978-93-91882-00-6/ch5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
药物如\(\beta\) -阻滞剂(阿替洛尔,普萘洛尔,美托洛尔),ACE抑制剂(卡托普利,依那普利,赖诺普利,雷米普利,福辛普利,喹诺普利),血管紧张素(AT1)受体阻滞剂(氯沙坦,坎地沙坦,缬沙坦,替米沙坦),\(\alpha\) -阻滞剂(普拉唑嗪,特拉唑嗪,多沙唑嗪,酚妥拉明,苯氧苄胺),中枢交感神经抑制剂(氯定,甲基多巴),心脏糖苷(地高辛、地高辛)、交感神经药物(肾上腺素、多巴胺、异丙肾上腺素)、抗胆碱能药物(阿托品、东莨菪碱)、黄嘌呤(茶碱、可可碱)、硝酸盐(三硝酸甘油、硝酸异山梨酯)、钙拮抗剂(维拉帕米、地尔硫卓)和k通道开放剂(尼可地尔)用于治疗心血管疾病bbb。最近对全球范围内地表水中心血管药物的发生情况进行了研究。这项研究有82种心血管药物,其中58种(71种)%) were detected at least once in the water bodies. The study also revealed that only 10% of the aquatic pollution was caused by the commonly prescribed antihypertensives (6% by angiotensin receptor-II antagonist and 4% by ACE inhibitors). The maximum contribution as a source of pollutants were from \(\beta\)-blockers (atenolol, metoprolol, and propranolol) at 38% and 36% to lipid regulating agents (gemfibrozil, bezafibrate and clofibric acid). The ecotoxicity caused by these cardiovascular drugs was further limited to about 24%. The drugs that are a major risk to the aquatic organisms include propranolol, metoprolol, lipid regulating agents, bezafibrate, and atorvastatin. The partition coefficient (Log P) value of cardiovascular drugs ranges from 0.6 for atenolol to 7.7 for telmisartan that results in bioaccumulation in the environmental matrices. Based on the presence of cardiovascular drugs in the aquatic ecosystem, the water pollutants are divided into three major contaminants, municipal water, surface water, and drinking water.
Pharmaceuticals as Pollutants in the Aquatic Ecosystem – Cardiovascular, Anti-diabetic, Steroids and Related Drugs
Drugs like \(\beta\)-blockers (atenolol, propranolol, metoprolol), ACE inhibitors (captopril, enalapril, lisinopril, ramipril, fosinopril, quinapril), angiotensin (AT1) receptor blockers (losartan, candesartan, valsartan, telmisartan), \(\alpha\)-blockers (prazosin, terazosin, doxazosin, phentolamine, phenoxybenzamine), central sympatholytics (clonidine, methyldopa), cardiac glycosides (digoxin, digitoxin), sympathetic drugs (adrenaline, dopamine, isoprenaline), anticholinergic drugs (atropine, scopolamine), xanthines (theophylline, theobromine), nitrates (glyceryl trinitrate, isosorbide dinitrate), calcium antagonists (verapamil, diltiazem) and K-channel openers (nicorandil) are used for the treatment of the cardiovascular disorder [1]. Recently a study was conducted on the occurrence of cardiovascular drugs in surface waters at a global scale. The study had 82 cardiovascular drugs out of which 58 (~71%) were detected at least once in the water bodies. The study also revealed that only 10% of the aquatic pollution was caused by the commonly prescribed antihypertensives (6% by angiotensin receptor-II antagonist and 4% by ACE inhibitors). The maximum contribution as a source of pollutants were from \(\beta\)-blockers (atenolol, metoprolol, and propranolol) at 38% and 36% to lipid regulating agents (gemfibrozil, bezafibrate and clofibric acid). The ecotoxicity caused by these cardiovascular drugs was further limited to about 24%. The drugs that are a major risk to the aquatic organisms include propranolol, metoprolol, lipid regulating agents, bezafibrate, and atorvastatin. The partition coefficient (Log P) value of cardiovascular drugs ranges from 0.6 for atenolol to 7.7 for telmisartan that results in bioaccumulation in the environmental matrices. Based on the presence of cardiovascular drugs in the aquatic ecosystem, the water pollutants are divided into three major contaminants, municipal water, surface water, and drinking water.